- Home
- ALLE vs SNN Comparison
ALLE vs SNN Comparison
Compare ALLE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLE
- SNN
- Stock Information
- Founded
- ALLE 2013
- SNN 1856
- Country
- ALLE Ireland
- SNN United Kingdom
- Employees
- ALLE N/A
- SNN N/A
- Industry
- ALLE Diversified Commercial Services
- SNN Industrial Specialties
- Sector
- ALLE Consumer Discretionary
- SNN Health Care
- Exchange
- ALLE Nasdaq
- SNN Nasdaq
- Market Cap
- ALLE 12.7B
- SNN 13.2B
- IPO Year
- ALLE N/A
- SNN 1999
- Fundamental
- Price
- ALLE $167.20
- SNN $36.18
- Analyst Decision
- ALLE Hold
- SNN Hold
- Analyst Count
- ALLE 9
- SNN 3
- Target Price
- ALLE $163.67
- SNN $27.50
- AVG Volume (30 Days)
- ALLE 1.1M
- SNN 1.0M
- Earning Date
- ALLE 07-24-2025
- SNN 08-26-2025
- Dividend Yield
- ALLE 1.22%
- SNN 2.02%
- EPS Growth
- ALLE 14.50
- SNN 59.91
- EPS
- ALLE 7.20
- SNN 0.56
- Revenue
- ALLE $3,876,600,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- ALLE $7.84
- SNN $7.44
- Revenue Next Year
- ALLE $6.00
- SNN $5.37
- P/E Ratio
- ALLE $23.21
- SNN $32.43
- Revenue Growth
- ALLE 5.49
- SNN 5.35
- 52 Week Low
- ALLE $116.57
- SNN $23.69
- 52 Week High
- ALLE $170.11
- SNN $36.84
- Technical
- Relative Strength Index (RSI)
- ALLE 66.04
- SNN 72.07
- Support Level
- ALLE $163.06
- SNN $35.73
- Resistance Level
- ALLE $170.11
- SNN $36.84
- Average True Range (ATR)
- ALLE 2.51
- SNN 0.49
- MACD
- ALLE -0.26
- SNN 0.32
- Stochastic Oscillator
- ALLE 58.72
- SNN 89.86
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.